PolitiFact @PolitiFact
By law, the FDA is prohibited from publicly disclosing the existence of new drug applications until they are approved. Portions that fall under a FOIA exemption for trade secrets and confidential information must be removed prior to release, as in the case of the Pfizer document. — PolitiTweet.org